Centre for Health Services and Clinical Research, University of Hertfordshire, Hatfield, UK.
Independent Specialist Mental Health Pharmacist, UK.
J Appl Res Intellect Disabil. 2019 Nov;32(6):1375-1388. doi: 10.1111/jar.12643. Epub 2019 Jul 24.
People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects.
A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved.
Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities.
There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.
智障人士比一般人群更易出现健康问题，他们经常需要服用多种药物。因此，智障人士了解自己的药物及潜在的不良反应非常重要。
本研究采用范围综述的方法，探讨了智障人士对处方药物的认知、风险以及如何提高他们对药物的理解。
共纳入了 10 篇期刊文章。智障人士通常对他们的药物缺乏了解，包括药物的名称、用途以及何时、如何服用。参与者经常对药物的不良反应感到困惑或不知情。有时信息是向照顾者而不是智障人士解释的。一些干预措施和易于理解的信息有助于提高智障人士的知识水平。
需要为智障人士提供关于药物的易于理解的信息，并与他们进行讨论，这符合法律和最佳实践标准。
